BioACCESS Projects
BioACCESS research focuses on building analytical tools that can help promote more equitable access to essential biologic medicines, including recombinant proteins, monoclonal antibodies, and vaccines.
BioACCESS is building computational tools that quantitatively evaluate the impact of manufacturing decisions, such as number and location of facilities within global manufacturing networks, on long-term financial and supply risks.
This project is developing data-driven statistical models of strategic manufacturing and supply operations that will be essential for rapid and equitable global distribution of a SARS-CoV-2 vaccine.